Healthcare Services

Therapeutic Plasma Exchange Market Forecast Assessing Growth Potential And Industry Direction

June 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Expected Market Size Of The Therapeutic Plasma Exchange Market In 2026 And How Much Will It Reach By 2030?

The therapeutic plasma exchange market has experienced robust expansion in recent years. Its valuation is projected to increase from $1.61 billion in 2025 to $1.76 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.4%. The historical rise can be attributed to several factors, including increased diagnosis of autoimmune disorders, the expansion of hospital transfusion services, the availability of centrifugation-based technologies, growing clinician familiarity with apheresis procedures, and the adoption of standardized treatment protocols.

The therapeutic plasma exchange market is anticipated to experience robust expansion over the coming years. Its value is projected to reach $2.4 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.0%. This anticipated growth is primarily driven by the increasing need for advanced autoimmune therapies, broader implementation of membrane separation technology, the expansion of outpatient apheresis services, increased investment in blood purification technologies, and a greater emphasis on personalized immunological treatments. Key trends expected during this period include the wider adoption of automated plasma exchange systems, the escalating application of tpe in neurological disorders, a rising requirement for high-efficiency separation technologies, the enlargement of hospital-based apheresis units, and an intensified focus on treatment safety and monitoring.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15683&type=smp

Which Significant Factors Are Encouraging Growth In The Therapeutic Plasma Exchange Market?

The increasing occurrence of blood-related conditions is anticipated to drive the expansion of the therapeutic plasma exchange market in the future. Blood disorders, also known as hematological disorders, are medical issues impacting blood and its formative tissues, such as the bone marrow, lymph nodes, and spleen. These disorders are on the rise, influenced by factors like genetic susceptibility, environmental elements, and shifts in lifestyle. Therapeutic plasma exchange (TPE) serves to eliminate disease-causing agents from the plasma in hematological disorders, for instance, autoantibodies in autoimmune hemolytic anemia or immune complexes in thrombotic thrombocytopenic purpura, which in turn lessens disease severity and enhances patient results. As an illustration, a report from Cancer Research UK, a UK-based charity, in July 2024, projects that the yearly average of new Hodgkin lymphoma cases in the UK will climb from about 2,400 cases between 2023 and 2025 to roughly 2,900 cases between 2038 and 2040. Consequently, the widespread occurrence of hematological disorders is fueling the expansion of the therapeutic plasma exchange market.

Which Segment Divisions Form The Structure Of The Therapeutic Plasma Exchange Market?

The therapeutic plasma exchange market covered in this report is segmented –

1) By Type: Therapeutic Plasma Exchange (TPE), Double Filtered Plasmapheresis (DFPP)

2) By Indication: Neurological Disorders, Hematological Disorders, Renal Disorders, Metabolic Disorders, Other Indications

3) By Technology: Centrifugation, Membrane Separation

4) By End User: Blood Collection Centers, Hospitals And Clinics, Transfusion Centers, Other End Users

Subsegments:

1) By Therapeutic Plasma Exchange (TPE): Manual TPE, Automated TPE

2) By Double Filtered Plasmapheresis (DFPP): Single-Stage DFPP, Multi-Stage DFPP

Which Trends Are Expected To Shape The Therapeutic Plasma Exchange Market?

Leading companies within the theranostics market are prioritizing the creation of cutting-edge solutions, including theranostics clinical trials, with the goal of advancing personalized medicine and elevating patient outcomes through the integration of diagnostic tools and therapeutic interventions into a unified treatment method. These trials represent research investigations that assess the concurrent application of diagnostic evaluations and focused treatments to customize therapeutic plans for specific patients. The objective of these studies is to ascertain the efficacy of particular treatments by considering biomarkers unique to each patient, consequently bolstering personalized medicine. As an illustration, during May 2024, BAMF Health, a US-based cancer treatment center, initiated the COMBAT Trial, formally named “A Phase I/II Theranostic Study of 64Cu-SAR-BBN and 67Cu-SAR-BBN for Identification and Treatment of GRPR-expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617” (NCT05633160). Notable aspects of this trial encompass a swift activation procedure via BAMF Health’s BAMF RapAct program, which allowed the study to commence in only seven weeks, along with an emphasis on employing novel radiopharmaceuticals designed to target the Gastrin-Releasing Peptide receptor (GRPR), intending to enhance treatment alternatives for patients with restricted therapeutic choices.

Who Are The Key Market Participants In The Therapeutic Plasma Exchange Market?

Major companies operating in the therapeutic plasma exchange market are Medica S.p.A., Fresenius SE and Co. KGaA, Medtronic Plc., Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, Kaneka Corporation, Octapharma AG, Haemonetics Corporation, Miltenyi Biotec Technology And Trading Co. Ltd., Macopharma SA, Cerus Corporation, Apellis Pharmaceuticals Inc., ImmunoTek Bio Centers LLC, CytoSorbents Corporation, Kawasumi Laboratories America Inc.

Access The Complete Therapeutic Plasma Exchange Market Report:

https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report

Which Geographic Region Represents The Largest Therapeutic Plasma Exchange Market Share?

North America was the largest region in the therapeutic plasma exchange market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the therapeutic plasma exchange market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Therapeutic Plasma Exchange Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=15683&type=smp

Browse Through More Reports Similar to the Global Therapeutic Plasma Exchange Market 2026, By The Business Research Company

Convalescent Plasma Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Plasma Protein Therapeutics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

Blood Plasma Derivatives Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795